XJ103
/ Starmab Biologics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 27, 2024
A Phase I Study of XJ103 in Chinese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=38 | Active, not recruiting | Sponsor: Starmab biologics（Shanghai）Co,.ltd | Not yet recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Pneumococcal Infections
1 to 1
Of
1
Go to page
1